July 1, 2025

From Glass Slides to Strategic Data: How Patholytix Scanning Powers Research at Scale

In pharmaceutical R&D, glass slides represent one of the most valuable yet underleveraged assets. These physical records contain decades of study insights, histological patterns, and high-stakes decisions.

May 14, 2025

5 Things You Didn’t Know About Patholytix

Patholytix introduced a new era for digital pathology, but even for those familiar with our platform, there are capabilities and use cases that remain under the radar.

April 29, 2025

How Patholytix Accelerates Study Timelines in Research

Pharmaceutical R&D runs on precision, but speed is what separates discovery from delivery.

April 17, 2025

Reinventing Slide Management in Research Pathology with Patholytix

The modern pharmaceutical research environment is awash with data, yet the management of one of its most critical assets (pathology slides) remains stubbornly inefficient.

February 11, 2025

Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions

Charles River Laboratories International, Inc. (NYSE: CRL) and Deciphex, a leader in AI-powered digital pathology, today announced the next phase of a strategic collaboration to focus on advancing cutting-edge image management solutions

January 21, 2025

Deciphex Launches Diagnexia Analytix: Revolutionising Pathology Services for Translational Research and Development with Advanced AI-Driven Insights

Deciphex, the research pathology division of Deciphex, proudly announces the launch of Diagnexia Analytix, a comprehensive pathology service offering that integrates advanced analytics and AI-powered workflows with expert-led diagnostics to elevate study outcomes.

January 7, 2025

Deciphex Secures €31M Series C to Address Global Pathology Shortage

Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising €31 million to address the acute global pathology crisis.

September 16, 2024

Launch of IHI JU VICT3R Initiative to Revolutionize Nonclinical Drug and Chemical Safety Evaluation with Virtual Controls

Deciphex today announced the launch of VICT3R, a groundbreaking initiative aimed at transforming nonclinical drug and chemical safety evaluation

May 30, 2024

Patholytix 4.0, Becomes First Platform to Support Future-proof Study Archival of Regulated Digital Safety Studies

Deciphex, a pioneering leader in GLP-compliant digital pathology solutions, announces today that it is the first DICOM-native platform to fully facilitate the archival and reconstruction of regulated digital studies. Previously unavailable, this advancement strengthens digital pathology's use in GLP drug safety assessment.

April 23, 2024

Deciphex Enters into Collaboration Agreement with Novartis to Advance AI in Preclinical Studies

Collaboration Agreement Seeks to engage AI to Transform Non-clinical Pathology Assessments in Drug Discovery and Development

April 11, 2024

Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology

Powered by digital pathology and AI algorithms, Patholytix Foresight drives speed and quality in toxicologic pathology practices

March 27, 2024

Deciphex Announce Web Based Enhancements to Patholytix, Enabling Any Time, Anywhere Peer Review

With the release of Patholytix 4.0, Deciphex introduces a new workflow, enabling users to access the platform through the web.

February 20, 2024

Deciphex Enables First Digital GLP Peer Review Conducted by a Consultant for a Contract Research Provider

In 2023, a Toxicological Pathologist at Integrated Biologix GmbH, Sarah Taplin, became the first consultant pathologist to perform a regulated digital peer review for a study conducted at a drug development research provider.

November 20, 2023

Synergies and Challenges in the Preclinical and Clinical Implementation of Pathology Artificial Intelligence Applications

September 14, 2023

Deciphex and Xybion Digital join forces to Infuse the Power of Micropathology Digital Slide Reading into Dynamic Non-clinical Study LIMS Workflows

Deciphex, a trailblazer in digitizing and networking global pathologists, has joined forces with Xybion, a global leader in unified cloud software solutions for regulated industries.

August 24, 2023

Deciphex Accepted into MHRA GLP Monitoring Programme and Imminent Attainment of GLP Certification at Exeter Site

Deciphex, a pioneering leader in digital pathology solutions, is pleased to announce the acceptance of, Diagnexia UK Limited, into the Medicines and Healthcare products Regulatory Agency (MHRA) GLP Monitoring Programme as a prospective member, and the expected achievement of Good Laboratory Practice (GLP) compliance statement for its cutting-edge facility located in Exeter.

July 31, 2023

AI Helps Pathologists Be More Certain Sooner

Digitisation and artificial intelligence is affecting how fast lifesaving drugs are developed

April 3, 2023

It's Time to End the Systemic Delays of Lifesaving Drugs

Digitisation and artificial intelligence is affecting how fast lifesaving drugs are developed

February 2, 2023

Deciphex Completes Validation Activities Enabling Veterinary Consultant Pathologists To Perform GLP Peer Review Digitally Using Patholytix

This major advance means that veterinary consultant pathologists can work entirely in the digital domain and maintain GLP-compliance throughout a peer review. 

January 12, 2023

Faster Study Delivery With Patholytix Automated Image QC

By building Automated Image QC into Patholytix 3.0, Deciphex delivers dramatically faster turnarounds of studies.

December 15, 2022

Patholytix Introduces Digital Pathology Review And Scoring In A Single Platform For The First Time

With Patholytix 3.0, Deciphex overcomes one of the last barriers to full-scale adoption of digital pathology.

September 13, 2022

Patholytix Validated for GLP Primary and Peer Review

Reduces Time and Cost of Safety Assessment Studies.

June 23, 2022

Deciphex Presents Poster at STP 2022 - “Using AI Based Nuclear Segmentation to Infer Toxicologic Pathology Outcomes such as Liver Hypertrophy from Cell Density Maps”

This week we were thrilled to get the opportunity to present our poster on the topic “Using AI Based Nuclear Segmentation to Infer Toxicologic Pathology Outcomes such as Liver Hypertrophy from Cell Density Maps”.

June 7, 2022

Deciphex Enables Digital Pathology Primary Review for GLP Studies

Deciphex have announced today that they are first in industry to offer clients Good Laboratory Practice (GLP) compliant digital primary review.

May 18, 2022

Deciphex at SFPT Congress 2022

Deciphex is participating in the French Society of Toxicological Pathology (SFPT) Congress 2022 in Toulouse, from the 19th - 20th of May.

May 3, 2022

Deciphex Launch Fully Outsourced AI Services for Non-clinical Digital Pathology

Deciphex have announced today that it is now a full service provider in Pathology AI and Quantitative Pathology.

March 22, 2022

Deciphex at Society of Toxicology (SOT) 61st Annual Meeting and ToxExpo

Deciphex is exhibiting at the Society of Toxicology (SOT) 61st Annual Meeting and ToxExpo happening in San Diego, California, from the 27-31st of March.

March 16, 2022

Deciphex Announce the Release of New Service Which Enables Veterinary Consultant Pathologists to Easily Onboard Digital Studies from their Partners via Patholytix Preclinical

Deciphex have introduced a new service to facilitate on-demand sharing of studies with any veterinary consultant pathologist on a pay-per-use basis with zero cost to the consultant.

March 15, 2022

Deciphex at Digital Pathology & AI Conference 2022

Our Director of Commercial AI Services for Research Pathology, Trevor Mc Kee will be speaking at the Digital Pathology & AI Conference 2022 happening virtually, from the 24-25th of March.

October 21, 2021

Utilizing Whole Slide Images for the Primary Evaluation and Peer Review of a GLP-Compliant Rodent Toxicology Study

The approach undertaken to deliver a Good Laboratory Practice (GLP) validation of whole slide images (WSIs) and the associated workflow for the digital primary evaluation and peer review of a GLP-compliant rodent inhalation toxicity study is described.

September 7, 2021

Experience Patholytix at the Cutting Edge Pathology Virtual Congress this Month

Deciphex are pleased to announce our Gold Sponsorship of the 4th ESVP, ECVP and ESTP Cutting Edge Pathology Congress taking place on the 15th-17th of September.

July 5, 2021

Deciphex are delighted to announce the launch of Patholytix Preclinical 2.1

This latest release of our award winning digital pathology platform delivers significant workflow improvements for our users and provides even greater support for early stage research applications through the introduction of Quantitative Pathology.

February 10, 2021

Evaluation of the Use of Single- and Multi-Magnification Convolutional Neural Networks for the Determination and Quantitation of Lesions in Nonclinical Pathology Studies

December 9, 2020

Deciphex Delivers Industry-first Patholytix Digital Pathology Peer Review for GLP Studies in Partnership with Charles River Laboratories

Deciphex and Charles River Laboratories International, Inc. (NYSE: CRL) have jointly announced today that they are the first in the industry to offer clients Good Laboratory Practice (GLP) validated digital peer review, using Deciphex Patholytix Preclinical for toxicologic pathology.

October 14, 2020

Using Deep Learning Artificial Intelligence Algorithms to Verify N-Nitroso-N-Methylurea and Urethane Positive Control Proliferative Changes in Tg-RasH2 Mouse Carcinogenicity Studies

October 13, 2020

Deciphex launch Patholytix Preclinical 2.0 enabling GLP Digital Pathology Peer Review

At Deciphex our mission is to enable our users to facilitate digital peer review of non-clinical pathology studies. We are delighted to announce the upcoming launch of Patholytix Preclinical 2.0 which provides our clients with a pathway to a regulated GLP Peer Review in conjunction with their CRO partners.

September 7, 2020

PODCAST: How Deciphex is Accelerating the Non-clinical Drug Development Phase - Interview with Aleksandra Zuraw

Our CEO Donal O’Shea featured on the Digital Pathology Space’s podcast hosted by Aleksandra Zuraw this week to discuss how Deciphex is accelerating the non-clinical drug development phase.

August 18, 2020

Deciphex are delighted to announce the launch of Patholytix AI 1.5

To mark the recent launch of Patholytix AI 1.5, we describe how Patholyix AI fits in the technology landscape available to AI developers working on Pathology AI projects, and how the platform can benefit them in accelerating impactful data generation for their pathology stakeholders.

July 4, 2020

Patholytix Preclinical 1.4 with Work from Home Mode

We understand that many of our partners now face changing work practices and are more reliant now than ever on remote collaborative tools to manage their day to day operations. Our team remains as committed and as capable as ever to supporting you, and to help you protect business continuity.

May 29, 2020

Deciphex open US office in Chicago, Implement high throughput scanning service for clients.

Deciphex are delighted to announce the opening of its first US Facility as part of our planned US expansion. The facility in Naperville will be a scanning and research centre, to support our collaboration with GI Partners of Illinois and to provide valuable scanning capacity for our pharma and research clients.

March 30, 2020

Charles River Laboratories and Deciphex Form a Partnership to Enhance Drug Discovery & Development with Digital Pathology

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a partnership with Deciphex, a leader in preclinical digital pathology software-as-a-service.

December 5, 2019

Global Engage - Digital Pathology Conference UK 2019

Consortium partners Janssen and Deciphex both attended and presented at the 6th Annual Global Engage Digital Pathology and AI congress in London on the 5th of December 2019.

December 4, 2019

PATHTOX 1st Annual review meeting

A 1st-year review meeting was conducted with all consortium partners in London in December 2019 prior to the annual global engage conference.

June 25, 2019

PATHTOX On-Site Workshop

A round table meeting was organised between the Deciphex team and various members of the pathology, quality & regulatory and statistical departments of Janssen, to introduce the project to the internal team in Janssen.

December 5, 2018

Kickoff meeting for PATHTOX FTI project

A kick-off meeting was held in London which Deciphex, Janssen and PDS attended.